Cite
MLA Citation
K. Chi et al.. “2504 Genomic predictive and prognostic factors from plasma cell-free DNA (cfDNA) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) commencing enzalutamide (ENZ).” European journal of cancer, vol. 51, n.d., pp. S474–S475. http://access.bl.uk/ark:/81055/vdc_100030628240.0x000057